| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,522 | 13,725 | 11,822 | 11,482 | | Cost of Revenue | 18,520 | 16,562 | 14,727 | 12,476 | | | Gross Profit | (2,998) | (2,837) | (2,905) | (994) | | | Operating Expenses | | Research Development | 2,271 | 761 | 2,076 | 2,048 | | Selling General and Administrative | 6,840 | 6,223 | 6,929 | 7,048 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,109) | (9,821) | (11,910) | (10,090) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19,558) | (5,189) | 25 | 135 | | Earnings Before Interest And Taxes | (31,667) | (15,010) | (11,885) | (9,955) | | Interest Expense | 143 | 132 | 69 |
-
| | Income Before Tax | (31,810) | (15,142) | (11,954) | (9,955) | | Income Tax Expense | 71 | 117 |
-
| 80 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31,881) | (15,259) | (11,954) | (10,035) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (31,881) | (15,259) | (11,954) | (10,035) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31,881) | ($15,259) | ($11,954) | ($10,035) |
|
0.51% Nasdaq 
0.01 (0.79%) 
Income Statement
